(Reuters) – Gilead Sciences Inc. The biopharmaceutical company will receive Immunomidics Inc. The two companies said in a joint statement on Sunday that for 21 21 billion, a move that would strengthen its cancer portfolio by acquiring promising drugs by access. The deal provides access to Immunomidix’s breast cancer treatment, …
Read More »Yearly Archives: 2020
China News: Millions of people surveyed in China over fears of ‘psychological war’ World | News
A company linked to the Chinese military and intelligence agencies has obtained data on thousands of Austral Australians, with significant data leaked. That target includes celebrities, journalists and even the Prime Minister of Australia, Scott Morrison. Globally, about 2.4 million people were traced. Experts have described the move as a …
Read More »Protests erupt in Lancaster after fatal shooting of knife-wielding man: D.A.
Sunday in Lancaster, Pa. Police in riot gear stormed a rally on Friday, removing hundreds of protesters by truck. Police in riot gear stormed a rally on Friday, removing hundreds of protesters by truck. Biden controls push guns for less than 24 hours after shooting Lie Deputies The Lancaster District …
Read More »Dallas County reports 3 coronavirus-related deaths; 7-Day Average Falls Again – NBC 5 Dallas-Fort Worth
Dallas County health officials on Sunday reported three more coronavirus-related deaths and 156 new, confirmed cases of Covid-19. The three deaths reported Sunday by Dallas County Health and Human Services include: A man in his 50s who was a resident of a long-term care facility in the city of Dallas. …
Read More »New Graphene Face Mask has very high anti-bacterial efficacy, inactivating coronavirus
Dr. Yeni’s team uses a CO2 infrared laser system to produce graphene. The experiment results show that the graphene they make shows better anti-bacterial efficacy than fabrics with activated carbon fiber and molten fabrics. Credit: City University of Hong Kong Anti-bacterial efficacy is close to 100% under 10-minute sunlight and …
Read More »